DigestRedComo funciona
Red
/
Empresas
By
No verificado

Byondis B.V.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaOncologíaPublicidad/Marketing/Medios de comunicación/Comunicación

5 Comunicados de prensa

Ver todos los comunicados de prensa
17/05/2026
Farmacéutica
Publicidad/Marketing/Medios de comunicación/Comunicación
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development 
Fuente
Byondis B.V.
Editor
GLOBENEWSWIRE
1.00
0
17/04/2026
Eventos
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026
Fuente
Byondis B.V.
Editor
Business Wire
1.00
0
03/06/2025
Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors
Fuente
Byondis B.V.
Editor
Business Wire
1.00
0
24/03/2025
Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer
Fuente
Byondis B.V.
Editor
Business Wire
1.00
0
19/11/2024
Byondis Appoints Louis Denis, M.D., as Chief Medical Officer
Fuente
Byondis B.V.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0